…es targeting interleukin (IL)-5, IL-5 receptor α, IL-4/IL-13 or thymic stromal lymphopoietin in patients with COPD and biomarker-defined T2 inflammation wer…
All extracted drugs
Showing 3,061–3,120 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 394 of 876…y, deferiprone up to 1000 mg/day, vitamin E supplementation and donepezil. There was a modest improvement in ataxia and frequency of fall…
…utcome (adjusted OR, aOR 2.0, 95% CI 1.2 to 3.4, p=0.01), while r-pc-AN were associated with significantly lower odds of excellent outc…
… and cost-effective; in recent years, pre-exposure prophylaxis (PrEP), a biomedical prevention choice, has gained more recognition. …
…list screening. Clinical trials and clinical studies evaluating celecoxib, etoricoxib or rofecoxib in patients with IBD and musculoskelet…
…nd microbiome immunotherapy studies indicates that antibiotics, proton pump inhibitors, corticosteroids and other microbiome-modifying exposures may a…
…ted a similar experience after a previous anaesthetic involving propofol. This case highlights the importance of recognising propofol-in…
…ion-approved RNA therapies, including patisiran, vutrisiran and inclisiran, which employ lipid nanoparticle delivery systems, highlight th…
…ryptococcus neoformans, we started liposomal amphotericin B and flucytosine. Despite early improvement, he deteriorated around day 35 with …
…ltiple anti-VEGF agents, including ranibizumab, aflibercept and faricimab, over 19 months. Despite ongoing therapy, her SRF persisted and…